Drug Discovery · London, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of a modular protein platform designed to facilitate the scalable discovery of bi-specific biologics. Valink Therapeutics is based in London, United Kingdom and was founded in 2020. It was valued at $12.6 million at its seed round in Nov 2023, the last priced event on record. It has raised $20.5 million across 1 recorded round; the latest was a $7.6 million seed round in Nov 2023.
PMV mark · valuation
$12.6M
Oct 2026
Priced at
its seed round
Nov 2023
Total raised
$20.5M
Last round
Seed Round
Nov 2023
No prints on record
No secondary trades in Valink Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Valink Therapeutics with a free account
·The complete investor list: 18 names
·Watch Valink Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Valink Therapeutics stock.
